These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22591747)

  • 1. Simultaneous progression of oxidative stress, angiogenesis, and cell proliferation in prostate carcinoma.
    Pande D; Negi R; Karki K; Dwivedi US; Khanna RS; Khanna HD
    Urol Oncol; 2013 Nov; 31(8):1561-6. PubMed ID: 22591747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma.
    Guzel S; Kiziler L; Aydemir B; Alici B; Ataus S; Aksu A; Durak H
    Biol Trace Elem Res; 2012 Jan; 145(1):23-32. PubMed ID: 21809052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy.
    Shariat SF; Anwuri VA; Lamb DJ; Shah NV; Wheeler TM; Slawin KM
    J Clin Oncol; 2004 May; 22(9):1655-63. PubMed ID: 15117988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
    Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
    Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative damage markers as possible discriminatory biomarkers in breast carcinoma.
    Pande D; Negi R; Karki K; Khanna S; Khanna RS; Khanna HD
    Transl Res; 2012 Dec; 160(6):411-8. PubMed ID: 22885175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB p65 subunit DNA-binding activity: association with depleted antioxidant levels in breast carcinoma patients.
    Pande D; Karki K; Negi R; Khanna S; Khanna RS; Khanna HD
    Cell Biochem Biophys; 2013; 67(3):1275-81. PubMed ID: 23709312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
    Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E
    Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia.
    Ahmad R; Tripathi AK; Tripathi P; Singh S; Singh R; Singh RK
    In Vivo; 2008; 22(4):525-8. PubMed ID: 18712183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of 8-oxo-7, 8-dihydro-2'-deoxyguanosine and malondialdehyde levels as oxidative stress markers and antioxidant status in non-small cell lung cancer.
    Peddireddy V; Siva Prasad B; Gundimeda SD; Penagaluru PR; Mundluru HP
    Biomarkers; 2012 May; 17(3):261-8. PubMed ID: 22397584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
    Fukuda H; Tsuchiya N; Narita S; Kumazawa T; Horikawa Y; Inoue T; Saito M; Yuasa T; Matsuura S; Satoh S; Ogawa O; Habuchi T
    Oncol Rep; 2007 Nov; 18(5):1155-63. PubMed ID: 17914566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis.
    Tae K; El-Naggar AK; Yoo E; Feng L; Lee JJ; Hong WK; Hittelman WN; Shin DM
    Clin Cancer Res; 2000 Jul; 6(7):2821-8. PubMed ID: 10914730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study.
    Hietanen E; Bartsch H; Béréziat JC; Camus AM; McClinton S; Eremin O; Davidson L; Boyle P
    Eur J Clin Nutr; 1994 Aug; 48(8):575-86. PubMed ID: 7957003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and antioxidant status in prostate cancer patients: relation to Gleason score, treatment and bone metastasis.
    Battisti V; Maders LD; Bagatini MD; Reetz LG; Chiesa J; Battisti IE; Gonçalves JF; Duarte MM; Schetinger MR; Morsch VM
    Biomed Pharmacother; 2011 Oct; 65(7):516-24. PubMed ID: 21993000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.
    Strohmeyer D; Strauss F; Rössing C; Roberts C; Kaufmann O; Bartsch G; Effert P
    Anticancer Res; 2004; 24(3a):1797-804. PubMed ID: 15274358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
    Shang ZJ; Li JR
    J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The correlation of vascular endothelial growth factor with angiogenesis and p53 gene in laryngeal squamous cell carcinoma].
    Yaylaci A; Cakir S; Güneş P; Akkaynak AC; Naiboğlu B; Gökçeer T
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(3):105-11. PubMed ID: 16763427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis and prostate cancer: identification of a molecular progression switch.
    Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM
    Cancer Res; 2001 Mar; 61(6):2736-43. PubMed ID: 11289156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
    Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
    Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.